Insufficient scRNA-seq data for expression of GAPDHS at single-cell level.
Insufficient scRNA-seq data for expression of GAPDHS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 75% | 17.46 | 1348 / 1809 | 78% | 17.76 | 370 / 472 |
eye | 0% | 0 | 0 / 0 | 100% | 102.29 | 80 / 80 |
spleen | 30% | 1.29 | 72 / 241 | 0% | 0 | 0 / 0 |
prostate | 22% | 4.78 | 53 / 245 | 0% | 0.01 | 2 / 502 |
brain | 21% | 0.97 | 568 / 2642 | 0% | 0.00 | 1 / 705 |
intestine | 21% | 1.54 | 201 / 966 | 0% | 0 | 0 / 527 |
breast | 19% | 3.54 | 85 / 459 | 1% | 0.02 | 10 / 1118 |
thymus | 17% | 1.83 | 108 / 653 | 0% | 0.03 | 3 / 605 |
kidney | 15% | 1.00 | 13 / 89 | 0% | 0.01 | 4 / 901 |
uterus | 12% | 0.65 | 21 / 170 | 0% | 0.01 | 1 / 459 |
adipose | 12% | 0.87 | 142 / 1204 | 0% | 0 | 0 / 0 |
stomach | 11% | 0.57 | 40 / 359 | 0% | 0.01 | 1 / 286 |
esophagus | 10% | 0.91 | 146 / 1445 | 1% | 0.01 | 1 / 183 |
ovary | 9% | 0.36 | 17 / 180 | 1% | 0.02 | 3 / 430 |
pancreas | 9% | 0.41 | 29 / 328 | 1% | 0.01 | 1 / 178 |
lung | 9% | 0.55 | 50 / 578 | 1% | 0.01 | 7 / 1155 |
blood vessel | 8% | 0.46 | 111 / 1335 | 0% | 0 | 0 / 0 |
liver | 8% | 0.59 | 18 / 226 | 0% | 0 | 0 / 406 |
adrenal gland | 8% | 0.54 | 20 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 7% | 0.30 | 65 / 929 | 0% | 0 | 0 / 0 |
heart | 6% | 0.26 | 48 / 861 | 0% | 0 | 0 / 0 |
bladder | 5% | 0.14 | 1 / 21 | 1% | 0.01 | 4 / 504 |
muscle | 5% | 1.34 | 43 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030317 | Biological process | flagellated sperm motility |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0006096 | Biological process | glycolytic process |
GO_0006006 | Biological process | glucose metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0050661 | Molecular function | NADP binding |
GO_0051287 | Molecular function | NAD binding |
GO_0004365 | Molecular function | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GAPDHS |
Protein name | Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic Glyceraldehyde-3-phosphate dehydrogenase, testis-specific (EC 1.2.1.12) (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2) (GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase) Glyceraldehyde-3-phosphate dehydrogenase, testis-specific (EC 1.2.1.12) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase) |
Synonyms | GAPDH2 HSD35 GAPD2 HSD-35 GAPDS |
Description | FUNCTION: May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility (By similarity). . FUNCTION: May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility. . |
Accessions | K7EP73 O14556 ENST00000586334.1 K7EMB2 ENST00000222286.9 ENST00000585510.1 |